• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CYTK

CYTK

Cytokinetics, Incorporated

NASDAQHealthcareBiotechnologyUS

USD70.71

-0.20 (-0.28%)

Rating:C

Company Profile

CEO

Robert I. Blum

IPO Date

2004-04-30

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$70.65

Prev. Close

$70.91

Day Low

$70.17

Day High

$71.76

52W Low

$31.52

52W High

$80.20

Market Cap

$8.80B

Volume

1.48M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

30.9%

Avg Negative

12.8%

Avg Neutral

56.4%

News Feed

Cytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF to Be Presented in Late Breaking Clinical Trials Session at the HFSA Annual Scientific Meeting

GlobeNewsWire·8/31/2021·↑ positive

Cytokinetics and Cure SMA Renew Partnership to Advance Education and Awareness of SMA

GlobeNewsWire·8/19/2021·↑ positive

Cytokinetics, Incorporated (CYTK) CEO Robert Blum on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/5/2021·↓ negative

Cytokinetics (CYTK) Reports Q2 Loss, Misses Revenue Estimates

Zacks Investment Research·8/5/2021·↑ positive

Cytokinetics: Q2 Earnings Insights

Benzinga·8/5/2021·↓ negative

Cytokinetics Announces Start of COURAGE-ALS, a Phase 3 Clinical Trial of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis

GlobeNewsWire·8/2/2021·↑ positive

Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks Investment Research·7/29/2021·↑ positive

Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

GlobeNewsWire·7/23/2021·↓ negative

Cytokinetics to Announce Second Quarter Results on August 5, 2021

GlobeNewsWire·7/22/2021·↑ positive

Why Cytokinetics (CYTK) Shares Are Trading Higher Today?

Benzinga·7/20/2021·↑ positive